Suppr超能文献

共生微生物群调节醛固酮。

Commensal microbiota regulate aldosterone.

作者信息

Moore Brittni N, Medcalf Alexandra D, Muir Rachel Q, Xu Chudan, Marques Francine Z, Pluznick Jennifer L

机构信息

Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.

School of Biological Sciences, Faculty of Medicine, Monash University, Clayton, Victoria, Australia.

出版信息

Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1032-F1038. doi: 10.1152/ajprenal.00051.2024. Epub 2024 Apr 18.

Abstract

The gut microbiome regulates many important host physiological processes associated with cardiovascular health and disease; however, the impact of the gut microbiome on aldosterone is unclear. Investigating whether gut microbiota regulate aldosterone can offer novel insights into how the microbiome affects blood pressure. In this study, we aimed to determine whether gut microbiota regulate host aldosterone. We used enzyme-linked immunosorbent assays (ELISAs) to assess plasma aldosterone and plasma renin activity (PRA) in female and male mice in which gut microbiota are intact, suppressed, or absent. In addition, we examined urinary aldosterone. Our findings demonstrated that when the gut microbiota is suppressed following antibiotic treatment, there is an increase in plasma and urinary aldosterone in both female and male mice. In contrast, an increase in PRA is seen only in males. We also found that when gut microbiota are absent (germ-free mice), plasma aldosterone is significantly increased compared with conventional animals (in both females and males), but PRA is not. Understanding how gut microbiota influence aldosterone levels could provide valuable insights into the development and treatment of hypertension and/or primary aldosteronism. This knowledge may open new avenues for therapeutic interventions, such as probiotics or dietary modifications to help regulate blood pressure via microbiota-based changes to aldosterone. We explore the role of the gut microbiome in regulating aldosterone, a hormone closely linked to blood pressure and cardiovascular disease. Despite the recognized importance of the gut microbiome in host physiology, the relationship with circulating aldosterone remains largely unexplored. We demonstrate that suppression of gut microbiota leads to increased levels of plasma and urinary aldosterone. These findings underscore the potential of the gut microbiota to influence aldosterone regulation, suggesting new possibilities for treating hypertension.

摘要

肠道微生物群调节许多与心血管健康和疾病相关的重要宿主生理过程;然而,肠道微生物群对醛固酮的影响尚不清楚。研究肠道微生物群是否调节醛固酮可以为微生物群如何影响血压提供新的见解。在本研究中,我们旨在确定肠道微生物群是否调节宿主醛固酮。我们使用酶联免疫吸附测定(ELISA)来评估雌性和雄性小鼠的血浆醛固酮和血浆肾素活性(PRA),这些小鼠的肠道微生物群完整、受到抑制或不存在。此外,我们还检测了尿醛固酮。我们的研究结果表明,抗生素治疗后肠道微生物群受到抑制时,雌性和雄性小鼠的血浆和尿醛固酮均会增加。相比之下,仅在雄性小鼠中观察到PRA增加。我们还发现,当没有肠道微生物群时(无菌小鼠),与传统动物(雌性和雄性)相比,血浆醛固酮显著增加,但PRA没有增加。了解肠道微生物群如何影响醛固酮水平可为高血压和/或原发性醛固酮增多症的发展和治疗提供有价值的见解。这些知识可能为治疗干预开辟新途径,例如使用益生菌或进行饮食调整,以通过基于微生物群的醛固酮变化来帮助调节血压。我们探讨了肠道微生物群在调节醛固酮中的作用,醛固酮是一种与血压和心血管疾病密切相关的激素。尽管肠道微生物群在宿主生理学中的重要性已得到认可,但其与循环醛固酮的关系在很大程度上仍未得到探索。我们证明,肠道微生物群的抑制会导致血浆和尿醛固酮水平升高。这些发现强调了肠道微生物群影响醛固酮调节的潜力,为治疗高血压提出了新可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b10/11381011/a8a8a44fba90/ajprenal.00051.2024_f000.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验